DDD Partners LLC Takes Position in Align Technology, Inc. $ALGN

DDD Partners LLC bought a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 9,228 shares of the medical equipment provider’s stock, valued at approximately $1,156,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Atria Investments Inc grew its stake in Align Technology by 4.9% during the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock worth $298,000 after buying an additional 74 shares in the last quarter. IFP Advisors Inc lifted its holdings in shares of Align Technology by 5.7% during the 2nd quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider’s stock worth $270,000 after acquiring an additional 77 shares during the period. Arizona State Retirement System boosted its position in shares of Align Technology by 0.4% during the 3rd quarter. Arizona State Retirement System now owns 20,387 shares of the medical equipment provider’s stock worth $2,553,000 after acquiring an additional 79 shares in the last quarter. Sentry Investment Management LLC increased its stake in Align Technology by 73.1% in the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 79 shares during the last quarter. Finally, Rothschild Investment LLC raised its position in Align Technology by 140.3% during the second quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 87 shares in the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Evercore ISI raised their target price on Align Technology from $180.00 to $200.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Stifel Nicolaus raised their price objective on Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Robert W. Baird set a $218.00 target price on Align Technology in a research note on Thursday, February 5th. Piper Sandler increased their target price on shares of Align Technology from $200.00 to $220.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Finally, Mizuho lifted their price target on shares of Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Seven analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $195.92.

Align Technology Trading Up 1.6%

NASDAQ:ALGN opened at $186.77 on Friday. The stock’s 50-day moving average is $167.07 and its 200-day moving average is $148.38. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $208.65. The stock has a market cap of $13.40 billion, a P/E ratio of 33.00, a price-to-earnings-growth ratio of 2.01 and a beta of 1.84.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 EPS for the quarter, topping the consensus estimate of $2.99 by $0.30. Align Technology had a net margin of 10.17% and a return on equity of 15.16%. The business had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period last year, the company earned $2.44 EPS. The firm’s revenue was up 5.3% compared to the same quarter last year. As a group, equities analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.